- Home
- NOMD vs VCYT Comparison
NOMD vs VCYT Comparison
Compare NOMD & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOMD
- VCYT
- Stock Information
- Founded
- NOMD 2014
- VCYT 2006
- Country
- NOMD United Kingdom
- VCYT United States
- Employees
- NOMD N/A
- VCYT N/A
- Industry
- NOMD Packaged Foods
- VCYT Medical Specialities
- Sector
- NOMD Consumer Staples
- VCYT Health Care
- Exchange
- NOMD Nasdaq
- VCYT Nasdaq
- Market Cap
- NOMD 2.6B
- VCYT 2.4B
- IPO Year
- NOMD N/A
- VCYT 2013
- Fundamental
- Price
- NOMD $15.53
- VCYT $30.34
- Analyst Decision
- NOMD Strong Buy
- VCYT Buy
- Analyst Count
- NOMD 4
- VCYT 9
- Target Price
- NOMD $21.00
- VCYT $39.89
- AVG Volume (30 Days)
- NOMD 1.3M
- VCYT 1.3M
- Earning Date
- NOMD 08-06-2025
- VCYT 08-06-2025
- Dividend Yield
- NOMD 4.42%
- VCYT N/A
- EPS Growth
- NOMD 6.08
- VCYT N/A
- EPS
- NOMD 1.57
- VCYT 0.34
- Revenue
- NOMD $3,605,402,231.00
- VCYT $479,129,000.00
- Revenue This Year
- NOMD $1.01
- VCYT $14.19
- Revenue Next Year
- NOMD $2.24
- VCYT $9.68
- P/E Ratio
- NOMD $9.91
- VCYT $90.43
- Revenue Growth
- NOMD 0.29
- VCYT 19.91
- 52 Week Low
- NOMD $14.72
- VCYT $22.61
- 52 Week High
- NOMD $20.81
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- NOMD 44.24
- VCYT 60.82
- Support Level
- NOMD $15.26
- VCYT $28.25
- Resistance Level
- NOMD $15.60
- VCYT $31.30
- Average True Range (ATR)
- NOMD 0.34
- VCYT 1.10
- MACD
- NOMD 0.09
- VCYT 0.01
- Stochastic Oscillator
- NOMD 68.07
- VCYT 72.65
About NOMD Nomad Foods Limited
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.